Evidence map›Paper›PMID 24759660›Full record

ArticlePloS one2014

Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.

Emilie Fugier, Hélène Marche, Marie-Ange Thélu, Zuzana Macek Jílková, Nicolas Van Campenhout, Tania Dufeu-Duchesne, Vincent Leroy, Jean-Pierre Zarski, Nathalie Sturm, Patrice N Marche and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The antifibrotic role of natural killer cells in liver fibrosis.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Emilie FugierINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France.
Hélène MarcheINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France.
Marie-Ange ThéluINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France; CHU-Grenoble, Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble, France.
Zuzana Macek JílkováINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France.
Nicolas Van CampenhoutINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France.
Tania Dufeu-DuchesneINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France; CHU-Grenoble, Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble, France.
Vincent LeroyINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France; CHU-Grenoble, Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble, France.
Jean-Pierre ZarskiINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France; CHU-Grenoble, Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble, France.
Nathalie SturmINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France; CHU-Grenoble, Département d'Anatomie et de Cytologie Pathologiques, Grenoble, France.
Patrice N MarcheINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France; CHU-Grenoble, Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble, France.
Evelyne Jouvin-MarcheINSERM, U823, Grenoble, France; Université Joseph Fourier, UMR-S823, Grenoble, France.
Université Joseph Fourier · FRInserm · FRCentre Hospitalier Universitaire de Grenoble · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During chronic hepatitis C virus (HCV) infection, the role of intra-hepatic (IH) natural killer (NK) cells is still controversial. To clarify their functions, we investigated anti-viral and cytotoxic activity of NK cells in human fresh liver biopsies. We compared the functions of IH-NK cells in HCV-infected and NASH patients in physiological conditions as well as after stimulation using flow cytometric and immunohistochemical analyses. Interestingly, few IH-NK cells produced anti-viral cytokine IFN-γ in HCV-infected patients similarly as in non-infected individuals. Spontaneous degranulation activity was extremely low in peripheral NK cells compared to IH-NK cells, and was significantly higher in IH-NK cells from HCV-infected patients compared to non-infected individuals. Immunohistochemical analysis revealed that perforin granules were polarized at the apical pole of IH-NK cells. The presence of CD107a and perforin in IH-NK cells demonstrated that NK cells exerted a cytolytic activity at the site of infection. Importantly, IH-NK cell functions from HCV-infected patients were inducible by specific exogenous stimulations. Upon ex vivo K562 target cell stimulations, the number of degranulating NK cells was significantly increased in the pool of IH-NK cells compared to circulating NK cells. Interestingly, after stimulation, the frequency of IFN-γ-producing IH-NK cells in HCV-infected patients was significantly higher at early stage of inflammation whereas the spontaneous IH-NK cell degranulation activity was significantly impaired in patients with highest inflammation and fibrosis Metavir scores. Our study highlights that some IH-NK cells in HCV-infected patients are able to produce INF-γ and degranulate and that those two activities depend on liver environment including the severity of liver injury. Thus, we conclude that critical roles of IH-NK cells have to be taken into account in the course of the liver pathogenesis associated to chronic HCV infection.

Indexed as

Cell LineFlow CytometryHepatitis C, ChronicHumansImmunohistochemistryInterferon-gammaInterleukin-12Interleukin-18Killer Cells, NaturalLiverLiver CirrhosisProspective StudiesInterferon-gammaInterleukin-12Interleukin-18

Identifiers

PMID24759660
PMCPMC3997478
OpenAlexW2055722864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.